American Journal of Clinical Nutrition, Vol 63, 54-66, Copyright © 1996 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans

J Zempleni, JR Galloway and DB McCormick
Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.

The pharmacokinetics and utilization (flavocoenzyme synthesis) of orally and intravenously administered riboflavin in healthy humans were assessed. After the determination of circadian rhythms of riboflavin concentrations in blood plasma and urine of four males and five females (control period), each of these subjects received three different oral riboflavin doses (20, 40, and 60 mg) and one intravenous bolus injection of riboflavin (11.6 mg). Vitamins were administered in a randomized, cross-over design with 2 wk between each administration. Blood plasma and urine specimens were collected repeatedly over a period of 48 h after each administration. Concentrations of flavocoenzymes and riboflavin were analyzed in blood plasma; riboflavin was assayed in urine. During the control period, a small circadian variation was observed: plasma concentrations and urinary excretion of riboflavin were low during the afternoon (P < 0.05). Pharmacokinetics were calculated using a two-compartment open model. The maximal amount of riboflavin that can be absorbed from a single dose was 27 mg per adult. Half-life of absorption was 1.1 h. First-order rate constants describing distribution and elimination of riboflavin were significantly higher after intravenous than after oral administration (P < 0.01). Release of flavocoenzymes into plasma was low compared with the increase of riboflavin concentrations. 7 alpha-Hydroxyriboflavin was identified in plasma. Clearance data indicated that urinary excretion of riboflavin contributes to one-half of the overall removal of riboflavin from plasma. No sex differences were observed for any of the pharmacokinetic variables (P > 0.05).

This article has been cited by other articles:

				J. R Dainty, N. R Bullock, D. J Hart, A. T Hewson, R. Turner, P. M Finglas, and H. J Powers Quantification of the bioavailability of riboflavin from foods by use of stable-isotope labels and kinetic modeling Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1557 - 1564. [Abstract] [Full Text] [PDF]

				K. C. Manthey, Y. C. Chew, and J. Zempleni Riboflavin Deficiency Impairs Oxidative Folding and Secretion of Apolipoprotein B-100 in HepG2 Cells, Triggering Stress Response Systems J. Nutr., May 1, 2005; 135(5): 978 - 982. [Abstract] [Full Text] [PDF]

				H. J Powers Riboflavin (vitamin B-2) and health Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1352 - 1360. [Abstract] [Full Text] [PDF]

				M. Navarro and R. J. Wood Plasma Changes in Micronutrients Following a Multivitamin and Mineral Supplement in Healthy Adults J. Am. Coll. Nutr., April 1, 2003; 22(2): 124 - 132. [Abstract] [Full Text] [PDF]

				G. Camporeale and J. Zempleni Oxidative Folding of Interleukin-2 Is Impaired in Flavin-Deficient Jurkat Cells, Causing Intracellular Accumulation of Interleukin-2 and Increased Expression of Stress Response Genes J. Nutr., March 1, 2003; 133(3): 668 - 672. [Abstract] [Full Text] [PDF]

				S. Hustad, M. C. McKinley, H. McNulty, J. Schneede, J.J. Strain, J. M. Scott, and P. M. Ueland Riboflavin, Flavin Mononucleotide, and Flavin Adenine Dinucleotide in Human Plasma and Erythrocytes at Baseline and after Low-Dose Riboflavin Supplementation Clin. Chem., September 1, 2002; 48(9): 1571 - 1577. [Abstract] [Full Text] [PDF]

				B. N Ames, I. Elson-Schwab, and E. A Silver High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658. [Abstract] [Full Text] [PDF]

				N. Yanagawa, R. N. G. Shih, O. D. Jo, and H. M. Said Riboflavin transport by isolated perfused rabbit renal proximal tubules Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1782 - C1786. [Abstract] [Full Text] [PDF]

				J. Zempleni and D. M. Mock Proliferation of Peripheral Blood Mononuclear Cells Increases Riboflavin Influx Experimental Biology and Medicine, October 1, 2000; 225(1): 72 - 79. [Abstract] [Full Text]

				S.-N. Huang and P. W. Swaan Involvement of a Receptor-Mediated Component in Cellular Translocation of Riboflavin J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 117 - 125. [Abstract] [Full Text]

				D. B. McCormick A Trail of Research on Cofactors: An Odyssey with Friends J. Nutr., February 1, 2000; 130(2): 323 - 323. [Abstract] [Full Text]

				S. Hustad, P. M. Ueland, and J. Schneede Quantification of Riboflavin, Flavin Mononucleotide, and Flavin Adenine Dinucleotide in Human Plasma by Capillary Electrophoresis and Laser-induced Fluorescence Detection Clin. Chem., June 1, 1999; 45(6): 862 - 868. [Abstract] [Full Text] [PDF]